Adult CML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase (NCT05143840) | University of Alabama at Birmingham | 2022-04-22 |
Track Adult CML automatically
Every clearance here is in the API, with alerts when new ones post.